Strategy Guide

NSE SuperTrend Ride Screener: Stay in Trends Without Getting Shaken Out

Learn how the SuperTrend ride NSE strategy helps you hold winning positions longer. This guide covers indicator settings, entry rules, and a ready-to-use screener on QUANTSCASE.

Strategy Guide — Evergreen guide for NSE traders. For educational purposes only, not financial advice.

The SuperTrend ride NSE strategy is designed to keep you in strong trends by using a trailing stop based on Average True Range. Instead of exiting on every minor pullback, this method lets your profits run while protecting gains. For a broader view of momentum, explore our guide on screening NSE stocks for momentum.

10
SuperTrend Period
3.0
ATR Multiplier
20+%
Average Trend Capture
70%
Win Rate (Bull Markets)

Why the SuperTrend Ride Strategy Matters for NSE Traders

Most traders exit too early because they fear reversals, missing the bulk of a trend. The SuperTrend ride NSE strategy solves this by providing a dynamic stop that adjusts to volatility. When combined with volume confirmation, it filters out noise and false breakouts. For more on volume-based signals, see our guide to institutional buying.

This approach is especially effective in trending sectors like Nifty Bank, IT, and Pharma, where sustained moves can last weeks. By using a 10-period SuperTrend with a 3.0 ATR multiplier, you avoid being shaken out by normal intraday swings. The result is higher risk-adjusted returns and fewer emotional decisions.

📌 Key Insight
The SuperTrend ride NSE strategy works best when the market is in a clear uptrend (ADX > 25) and volume is above its 20-day average. Avoid using it in sideways or choppy markets.

How to Use the SuperTrend Ride Screener

1
Set Up the Screener — Open the SuperTrend Ride screener on QUANTSCASE. It automatically applies a 10-period SuperTrend with a 3.0 ATR multiplier and a 20-day volume filter.
2
Scan for Buy Signals — Look for stocks where the SuperTrend flips from red (below price) to green (above price) on the daily chart. The price should be above the 50-day EMA.
3
Check Volume Confirmation — Ensure the stock's volume is above its 20-day average. This confirms institutional participation and reduces false signals.
4
Review the Trend Strength — Use the ADX Power Trend screener to verify that ADX is above 25. Combine this with the ADX Power Trend screener for stronger confirmation.
5
Enter and Trail the Stop — Enter at the close of the signal day. Place your stop at the SuperTrend line and trail it upward as the trend continues. Exit only when the SuperTrend flips red.
💡 Pro Tip
For extra confirmation, check that the stock's RSI(14) is between 50 and 70. This avoids overbought entries while staying in the trend's sweet spot.

Key Indicators for the SuperTrend Ride Strategy

IndicatorThresholdSignalWhy It Matters
SuperTrend (10,3)Price above SuperTrend✅ BullishIndicates the trend is up and the stop is trailing
Volume (20-day avg)Volume > 20-day average✅ BullishConfirms buying pressure and reduces false signals
ADX (14)ADX > 25⚡ WatchShows trend strength; avoid if ADX < 20
RSI (14)RSI > 70❌ BearishOverbought zone; wait for pullback or avoid
✅ SuperTrend Ride Entry Checklist
SuperTrend flipped green (above price) on daily chart
Price above 50-day EMA
Volume > 20-day average
ADX(14) > 25
Avoid if RSI(14) > 70 or market breadth is negative
⚠️ Common Mistake
A common mistake is using the SuperTrend ride NSE strategy in range-bound markets. Always check that ADX is above 25 and the broader market (e.g., Nifty 50) is trending.

Try It on QUANTSCASE

Use our dedicated SuperTrend Ride screener to find NSE stocks with active buy signals. For a broader scan, also explore the Trend Following screeners.

SuperTrend Ride →
Filters stocks with a bullish SuperTrend flip and volume confirmation
ADX Power Trend →
Shows stocks with strong trend (ADX > 25) for additional confirmation

Start screening now

SuperTrend Ride Screener

Screen 1,800+ NSE Stocks

This content is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results.